2023-08-24 10:55:38 ET
More on Galapagos
- Galapagos NV ( GLPG ) Q2 2023 Earnings Call Transcript
- Galapagos to transfer drug discovery and research activities in France to NovAliX
- Galapagos stock dips as Jyseleca fails phase 3 trial as induction therapy in Crohn's disease, cancels plan for EU filing
- Galapagos downgraded to market perform at Raymond James on unclear path forward
- Galapagos cut at Morgan Stanley on positive but slow transformation
- Galapagos stock dips after Jefferies slashes rating citing challenges ahead
For further details see:
Galapagos cut to Neutral at Citi on lack of catalysts